The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients. - Ismail G; Zeineddine M; Al-Roughani R; Ahmed SF; Al-Mahdawi A; Khoury S; El-Ayoubi N; Inshasi J; Al-Khabouri J; Al-Asmi A; Gouider R; Aljarallah S; et al. (Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026)